Caris Life Sciences Inc:企業の製品パイプライン分析

◆英語タイトル:Caris Life Sciences Inc - Product Pipeline Analysis, 2020 Update
◆商品コード:GDME53633PD
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD1,500 ⇒換算¥165,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥247,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Caris Life Sciences Inc (Caris Life) is a biotechnology company. The company’s molecular scientific offerings assess DNA, RNA and proteins to reveal a molecular blueprint that helps physicians and cancer patients make personalized treatment decisions. Its ADAPT biotargeting system, is a platform that identifies the novel molecular targets to inform and enhance drug development and advanced diagnostics. Caris Life provides healthcare information and comprehensive tumor profiling service through its Caris molecular intelligence; DEAN, a proprietary artificial intelligence analytics engine to analyze the whole exome, whole transcriptome and complete cancer proteome. The company’s products are used in therapeutic development, drug delivery, diagnostics and disease monitoring applications. The company offers its molecular solutions for patients, physicians, payers and biopharmaceutical organizations. The company has operations in Phoenix, the US and Basel, Switzerland. Caris Life is headquartered in Irving, Texas, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Caris Life Sciences Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Caris Life Sciences Inc Company Overview
Caris Life Sciences Inc Company Snapshot
Caris Life Sciences Inc Pipeline Products and Ongoing Clinical Trials Overview
Caris Life Sciences Inc – Pipeline Analysis Overview
Caris Life Sciences Inc – Key Facts
Caris Life Sciences Inc – Major Products and Services
Caris Life Sciences Inc Pipeline Products by Development Stage
Caris Life Sciences Inc Pipeline Products Overview
Companion Diagnostic Assay – Breast Cancer
Companion Diagnostic Assay – Breast Cancer Product Overview
Companion Diagnostic Assay – Pancreatic Cancer
Companion Diagnostic Assay – Pancreatic Cancer Product Overview
Companion Diagnostic Test – Rare FGFR Fusions
Companion Diagnostic Test – Rare FGFR Fusions Product Overview
Diagnostic Test – PSA
Diagnostic Test – PSA Product Overview
MI Exome
MI Exome Product Overview
MI Transcriptome
MI Transcriptome Product Overview
Caris Life Sciences Inc – Key Competitors
Caris Life Sciences Inc – Key Employees
Caris Life Sciences Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Caris Life Sciences Inc, Recent Developments
Sep 22, 2020: Caris Precision Oncology Alliance welcomes UT Southwestern Medical Center
Aug 25, 2020: Penn State Cancer Institute joins Caris Life Sciences’ Precision Oncology Alliance
Jul 21, 2020: Caris Precision Oncology Alliance welcomes Montefiore Health System
Feb 11, 2020: Caris Life Sciences appoints new Executive Medical Director
Dec 11, 2019: Caris Life Sciences launches first ever molecular AI product: A clinical genomic profiling similarity score
Dec 10, 2019: Caris Life Sciences to present data evaluating PI3K pathway alterations at the 2019 San Antonio Breast Cancer Symposium (SABCS)
Dec 04, 2019: Caris Life Sciences and Ambry Genetics partner to advance cancer care
Oct 15, 2019: Caris Life Sciences further bolsters scientific advisory board with four new members
Aug 20, 2019: Caris Life Sciences accelerates growth through development of pioneering state-of-the-art corporate park
Jul 23, 2019: University of Puerto Rico Joins Caris Life Sciences’ Precision Oncology Alliance
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Caris Life Sciences Inc Pipeline Products and Ongoing Clinical Trials Overview
Caris Life Sciences Inc Pipeline Products by Equipment Type
Caris Life Sciences Inc Pipeline Products by Indication
Caris Life Sciences Inc, Key Facts
Caris Life Sciences Inc, Major Products and Services
Caris Life Sciences Inc Number of Pipeline Products by Development Stage
Caris Life Sciences Inc Pipeline Products Summary by Development Stage
Companion Diagnostic Assay - Breast Cancer - Product Status
Companion Diagnostic Assay - Breast Cancer - Product Description
Companion Diagnostic Assay - Pancreatic Cancer - Product Status
Companion Diagnostic Assay - Pancreatic Cancer - Product Description
Companion Diagnostic Test - Rare FGFR Fusions - Product Status
Companion Diagnostic Test - Rare FGFR Fusions - Product Description
Diagnostic Test - PSA - Product Status
Diagnostic Test - PSA - Product Description
MI Exome - Product Status
MI Exome - Product Description
MI Transcriptome - Product Status
MI Transcriptome - Product Description
Caris Life Sciences Inc, Key Employees
Caris Life Sciences Inc, Other Locations
Glossary

★海外企業調査レポート[Caris Life Sciences Inc:企業の製品パイプライン分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Touchstone Exploration Inc (TXP):石油・ガス:M&Aディール及び事業提携情報
    Summary Touchstone Exploration Inc (Touchstone), formerly Touchstone Resources Ltd is an upstream oil and gas exploration and production company that explores, produces, and develops, oil and gas properties in Trinidad and Tobago. The company holds interests, owns, and operates projects such as WD-4 …
  • Toshiba Semiconductor Company:企業の戦略的SWOT分析
    Toshiba Semiconductor Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • Honeywell Advanced Fibers and Composites:企業の戦略・SWOT・財務情報
    Honeywell Advanced Fibers and Composites - Strategy, SWOT and Corporate Finance Report Summary Honeywell Advanced Fibers and Composites - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Magma Fincorp Limited:企業のM&A・事業提携・投資動向
    Magma Fincorp Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Magma Fincorp Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Halma Plc (HLMA):医療機器:M&Aディール及び事業提携情報
    Summary Halma Plc (Halma) develops, produces and sells life protection products to enhance personal and public health. The company’s product portfolio comprises fire detection and suppression systems, corrosion monitoring systems, gas detectors, elevator safety products, water treatment systems, aut …
  • The Madison Square Garden Co:企業の戦略・SWOT・財務情報
    The Madison Square Garden Co - Strategy, SWOT and Corporate Finance Report Summary The Madison Square Garden Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sigma-Tau HealthScience USA, Inc:企業の戦略・SWOT・財務情報
    Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report Summary Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • E. & J. Gallo Winery:企業の戦略・SWOT・財務情報
    E. & J. Gallo Winery - Strategy, SWOT and Corporate Finance Report Summary E. & J. Gallo Winery - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Hospira Inc:医療機器:M&Aディール及び事業提携情報
    Summary Hospira Inc (Hospira), a subsidiary of Pfizer Inc, is a medical device company that offers injectable drugs and infusion technologies. The company offers products such as generic acute-care and oncology injectables, biosimilars, infusion systems, IV sets, IV safety devices, biosimilars, diff …
  • The E. W. Scripps Company:企業の戦略・SWOT・財務情報
    The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report Summary The E. W. Scripps Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Micro Labs Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Micro Labs Ltd (Micro Labs) is a healthcare service organization which conducts research and development of bio equivalent generics. The organization’s business segments include formulations and active pharmaceutical ingredients. Its products include acetamide, allercet, amiodar, amlong, aml …
  • Banco Santander SA:企業の戦略・SWOT・財務分析
    Banco Santander SA - Strategy, SWOT and Corporate Finance Report Summary Banco Santander SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Japan Pulp and Paper Company Limited:企業の戦略・SWOT・財務分析
    Japan Pulp and Paper Company Limited - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Resverlogix Corp (RVX)-製薬・医療分野:企業M&A・提携分析
    Summary Resverlogix Corp (Resverlogix) is an epigenetics company that develops small molecule therapeutics for Bromodomain and ExtraTerminal Domain (BET) inhibition. The company provides lead product such as RVX-208 (apabetalone), is a BET inhibitor under phase III clinical trial. Its RVX-208 is bei …
  • Kohinoor Energy Limited (KOHE):企業の財務・戦略的SWOT分析
    Kohinoor Energy Limited (KOHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Dassault Systemes SA (DSY):医療機器:M&Aディール及び事業提携情報
    Summary Dassault Systemes SA (Dassault) is a 3D experience company that offers software applications and services. Dassault offers consulting services in the areas of design, deployment, support, training, and engineering services. The company serves various industries including aerospace and defens …
  • CK Infrastructure Holdings Ltd (1038):企業の財務・戦略的SWOT分析
    CK Infrastructure Holdings Ltd (1038) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Future Consumer Ltd (FCONSUMER):企業の財務・戦略的SWOT分析
    Future Consumer Ltd (FCONSUMER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Sahara Energy Ltd (SAH):石油・ガス:M&Aディール及び事業提携情報
    Summary Sahara Energy Ltd (Sahara Energy) is an oil and gas exploration and development company that acquires, exploits, explores, and develops oil and natural gas reserves in Western Canada. The company evaluates oil and gas exploration properties in Canada. It plans on growing through the drill bi …
  • ReNeuron Group Plc (RENE):製薬・医療:M&Aディール及び事業提携情報
    Summary ReNeuron Group Plc (ReNeuron) is a clinical-stage stem cell company which develops innovative stem cell therapies targeting areas of significant unmet medical need. The company’s therapeutic candidates in clinical development are focused at treating motor disability as a result of stroke, cr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆